Early tocilizumab treatment could improve survival among COVID-19 patients.

Early tocilizumab treatment could improve survival among COVID-19 patients. Clin Exp Rheumatol. 2020 May-Jun;38(3):578 Authors: Campins L, Boixeda R, Perez-Cordon L, Aranega R, Lopera C, Force L PMID: 32456769 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32456769?dopt=Abstract

Source: Clinical and Experimental Rheumatology - May 29, 2020 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research

More News: Actemra | COVID-19 | Rheumatology